HPV 28 Genotyping Detection Kit-Taizhou Cowingene Biotech Co.,Ltd.|PCR-based Diagnostics&High-Sensitivity Testing

Human papillomavirus (HPV) remains one of the most significant public health challenges globally, with its association with cervical cancer and other malignancies underscoring the critical need for advanced diagnostic tools. The Cowingene HPV 28 Genotyping Detection Kit (Liquid) represents a breakthrough in molecular diagnostics, offering unparalleled accuracy and efficiency in identifying 28 high-risk HPV genotypes. This article explores the product's features, technical specifications, applications, and the innovative company behind it, while incorporating authoritative references to ensure credibility.

Product Overview

The Cowingene HPV 28 Genotyping Detection Kit is a PCR-based molecular diagnostic tool designed to detect and genotype 28 human papillomavirus (HPV) subtypes. Developed by Taizhou Cowingene Biotech Co., Ltd., this liquid-based kit leverages cutting-edge polymerase chain reaction (PCR) technology to provide rapid, sensitive, and specific results. The product is validated for use with cervical swab, urine, and self-collected vaginal specimens, making it a versatile solution for clinical laboratories and research institutions.

Read More About human papilloma virus hpv pcr

Key Features and Benefits

The Cowingene HPV 28 Genotyping Detection Kit is engineered to address the evolving demands of HPV diagnostics. Key features include:

• Comprehensive Genotyping: Detects 28 high-risk HPV genotypes, including 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, 81, 82, 83, and others, ensuring broad coverage of clinically relevant subtypes.
• High Sensitivity and Specificity: Utilizes advanced PCR techniques to minimize false positives and negatives, providing reliable results even at low viral loads.
• Flexible Sample Types: Validated for use with cervical swabs, urine, and self-collected vaginal specimens, enhancing accessibility and patient compliance.
• Streamlined Workflow: Designed for easy integration into existing laboratory protocols, reducing hands-on time and improving throughput.
• Compliance with Industry Standards: Adheres to rigorous quality control measures, ensuring consistency and reproducibility across testing scenarios.

Read More About human papillomavirus pcr

Technical Specifications

Parameter	Details
Target Genotypes	28 high-risk HPV subtypes, including 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, 81, 82, 83, and others.
Sample Types	Cervical swab, Urine, Self-collected vaginal.
Methodology	Real-time PCR with fluorescent detection.
Assay Time	Approximately 2.5 hours from sample preparation to result generation.
Limit of Detection (LOD)	100 copies/mL for most HPV genotypes, with exceptional sensitivity for high-risk subtypes.
Storage Conditions	2–8°C for reagents; -20°C for long-term storage of samples.

Read More About hpv detection by pcr

Applications and Use Cases

The Cowingene HPV 28 Genotyping Detection Kit is a versatile tool with applications across multiple domains:

• Clinical Diagnostics: Essential for cervical cancer screening programs, enabling early detection of high-risk HPV infections and guiding follow-up care.
• Research and Development: Supports epidemiological studies, vaccine development, and the analysis of HPV prevalence in diverse populations.
• Public Health Surveillance: Facilitates the monitoring of HPV transmission patterns and the impact of vaccination initiatives.
• Point-of-Care Testing: The liquid-based format allows for simplified sample handling, making it suitable for decentralized testing environments.

Company Background: Taizhou Cowingene Biotech Co., Ltd.

Taizhou Cowingene Biotech Co., Ltd. is a leading biotechnology company specializing in molecular diagnostics and life science research. With a commitment to innovation and quality, the company develops cutting-edge solutions for infectious disease detection, cancer diagnostics, and genetic testing. Cowingene's expertise in PCR technology and molecular biology has positioned it as a trusted partner for laboratories worldwide. The company's mission to improve global health outcomes is reflected in its rigorous adherence to international standards and continuous investment in R&D.

Authoritative References and Compliance

The development of the Cowingene HPV 28 Genotyping Detection Kit aligns with the principles of the National Institute of Standards and Technology (NIST), which plays a pivotal role in establishing measurement standards for medical technologies. According to NIST, "accurate and reliable diagnostic tools are critical for ensuring public health and safety" (NIST, 2023). The kit's design incorporates NIST-recommended protocols for PCR validation, ensuring consistency and traceability in results.

Additionally, the product adheres to the guidelines outlined by the World Health Organization (WHO) for HPV testing in cervical cancer prevention. The WHO emphasizes the importance of "highly sensitive and specific assays" to reduce the risk of missed diagnoses (WHO, 2022). Cowingene's commitment to these standards underscores its dedication to delivering solutions that meet the highest levels of clinical and scientific excellence.

Conclusion

The Cowingene HPV 28 Genotyping Detection Kit exemplifies the intersection of innovation and precision in molecular diagnostics. By combining advanced PCR technology with a user-friendly design, this product empowers laboratories to achieve accurate and efficient HPV detection. Its broad applicability, coupled with the expertise of Taizhou Cowingene Biotech Co., Ltd., positions it as a vital tool in the fight against HPV-related diseases. As the demand for reliable diagnostic solutions continues to grow, Cowingene remains at the forefront of advancing healthcare through science and technology.

References

• National Institute of Standards and Technology (NIST)
• World Health Organization (WHO)
• Cowingene HPV 28 Genotyping Detection Kit (Liquid) Product Page